【作者】 吕维富； 季必勇； 鲁东； 周春泽； 侯昌龙； 肖景坤； 张正峰；

【机构】 安徽省立医院介入放射科；

【摘要】 目的:探讨CT引导下经皮射频消融治疗原发性单发小肝癌的临床疗效。方法:收集我院2009年4月~2012年1月≤3cm单发小肝癌在CT引导下行RFA治疗31例,术后定期随访,做出疗效评价。结果:31例单发31个病灶消融术后1月复查,25个(80.6%)病灶为完全消融,6个(19.4%)病灶呈不完全消融,随访中病灶稳定17个(54.8%),14个(45.2%)病灶进展,重复RFA后获得较为满意的治疗效果。所有患者均未出现严重不良反应及并发症。结论:RFA治疗原发性单发小肝癌具有疗效确切、安全性高、并发症低等优点,其近期生存率高,远期疗效尚待进一步随访观察。更多还原

【Abstract】 all hepatocellular carcinoma.Methods During the period from April 2009 to Jan.2012,percutaneous radiofrequency ablation under CT guidance was carried in 31 cases with ≤ 3 cm solitary small hepatocellular carcinoma.Regular follow-up indicators after me treatment were employed to estimate the clinical results.Results 31 cases of lesions after 1 month RFA review result,25 of which(80.6%) for fully ablation lesions,6(19.4%) focus is not complete ablation.Displayed in the follow-up process,all lesions in the stable 17(54.8%),14 lesions progress(45.2%).After repeated RFA treatment,these lesions are satisfied with the treatment effect.There was no treatment-related mortality in the studied group.Conclusion RFA is an effective and safe therapeutic approach for small hepatocellular carcinoma.Survival rate of RFA is high in the near future,but long-term curative effect of pending further follow-up.更多还原